NEW YORK, November 21, 2016 /PRNewswire/ --
Stock-Callers.com redirects investors' attention to the Medical Appliances and Equipment industry which is engaged in the
manufacture of medical instruments such as dental and surgical appliances. Companies to assess are: Lantheus Holdings Inc.
(NASDAQ: LNTH), Nevro Corp. (NYSE: NVRO), Steris PLC (NYSE: STE), and The Spectranetics Corp. (NASDAQ: SPNC). These equities
belong to the Healthcare sector which was mixed in pre-market trade on Friday, November 18, 2016.
Today's research reports on the aforementioned stocks are downloadable for free upon registration at: http://stock-callers.com/registration
Lantheus
Last Friday, Massachusetts headquartered Lantheus Holdings Inc.'s stock closed the day flat
at $9.25 with a total trading volume of 346,044 shares. The Company's shares have advanced 12.94%
in the previous three months and 173.67% on an YTD basis. The stock is trading 7.32% above its 50-day moving average and 95.43%
above its 200-day moving average. Additionally, shares of Lantheus, which develops, manufactures, and commercializes diagnostic
medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide, have a
Relative Strength Index (RSI) of 50.80.
On November 8th, 2016, research firm RBC Capital Markets reiterated its 'Outperform'
rating on the Company's stock with an increase of the target price from $6 a share to $12 a share.
On November 15th, 2016, Lantheus announced an agreement to sell 3,000,000 shares of
its common stock. The offering is expected to consist of 1,000,000 shares to be offered by the Company and 2,000,000 shares to be
offered by certain of its existing stockholders. The Company intends to use a combination of net proceeds from this offering,
together with cash on hand, to repay approximately $20 million of the outstanding principal balance
under its senior secured credit facilities. The Company will not receive any proceeds from the sale of shares by the selling
stockholders. Visit us today and access our complete research report on LNTH at: http://stock-callers.com/registration/?symbol=LNTH
Nevro
Shares in California headquartered Nevro Corp. rose 1.43%, finishing the session at
$89.55. The stock recorded a trading volume of 369,401 shares. The Company's shares have gained
32.65% since the start of this year. The stock is trading above its 200-day moving average by 16.49%. Furthermore, shares of
Nevro, which develops and commercializes a neuromodulation platform for the treatment of chronic pain in the US, Europe, and Australia, have an RSI of 48.50.
On November 8th, 2016, Nevro announced that it achieved revenue of $60.9 million in Q3 2016, an increase of 296% as reported, over Q3 2015. Gross profit for Q3 2016 was
$41.7 million, representing a 68% of gross margin, up from $9.4
million, representing a 61% of gross margin, in Q3 2015. The company recorded loss from operations for Q3 2016 of
$1.9 million compared to $17.7 million for Q3 2015. The complimentary
report on NVRO can be downloaded at: http://stock-callers.com/registration/?symbol=NVRO
Steris
UK-based Steris PLC's stock finished 0.29% lower at $66.22 with a total trading volume of
381,679 shares. Shares of the Company, which develops, manufactures, and markets infection prevention, contamination control,
microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific,
research, industrial, and governmental customers worldwide, are trading below their 200-day moving average by 3.93%. The stock
has an RSI of 41.19.
As per notes filed with the SEC on November 8th, 2016, STERIS identified certain
errors in its Consolidated Condensed Statement of Cash Flows and related calculation of Free Cash Flow for the six months ended
September 30th, 2016, which were originally published with the Company's Q2 FY17
financial results on November 2nd, 2016. As originally published, net cash provided by
operating activities, net cash used in investing activities, and net cash used in financing activities were $182.5 million, $13.3 million, and $151.1 million,
respectively. After corrections, net cash provided by operating activities, net cash used in investing activities, and net cash
used in financing activities were $188.5 million, $8.7 million and
$161.6 million, respectively. Free cash flow as originally published was $108.9 million and is now $119.4 million. Register for free on Stock-Callers.com
and access the latest research report on STE at: http://stock-callers.com/registration/?symbol=STE
The Spectranetics
Shares in Colorado Springs, Colorado headquartered The Spectranetics Corp. ended last
Friday's session 1.49% higher at $23.80 and with a total trading volume of 356,023 shares. The
stock has advanced 58.03% on an YTD basis. The Company's shares are trading 0.78% above their 50-day moving average and 20.97%
above their 200-day moving average. Moreover, shares of Spectranetics, which together with its subsidiaries, develops,
manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular
system, have an RSI of 55.67.
On October 21st, 2016, research firm Needham reiterated its 'Buy' rating on the
Company's stock with an increase of the target price from $27 a share to $32 a share. Get free access to your research report on SPNC at: http://stock-callers.com/registration/?symbol=SPNC
--
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@stock-callers.com .
Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the
document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information
which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to
veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a
company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA